antimalarials - CISMeF

Preferred Label : antimalarials;

MeSH definition : Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585);

MeSH synonym : anti malarials; antimalarial drugs; anti-malarials; antimalarial agents; agents, antimalarial; drugs, antimalarial; Antimalarial; Anti-Malarial; Anti Malarial; Antimalarial Drug; Drug, Antimalarial; Antimalarial Agent; Agent, Antimalarial;

Wikipedia automatic translation : Antimalarial medication;

Wikipedia link : https://en.wikipedia.org/wiki/Antimalarial medication;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000962;

UMLS CUI

C0003374;

ATC code(s)
- artenimol and piperaquine [ATC Code]
- methanolquinolines [ATC Code]
ATC code(s)
- Artemisinin and derivatives, combinations [ATC Code]
- Artemisinin and derivatives, plain [ATC Code]
- aminoquinolines [ATC Code]
- amodiaquine [ATC Code]
- antimalarials [ATC Code]
- artemether [ATC Code]
- artemether and lumefantrine [ATC Code]
- artemisinin [ATC Code]
- artemotil [ATC Code]
- artenimol and piperaquine [ATC Code]
- artesunate [ATC Code]
- artesunate and amodiaquine [ATC Code]
- artesunate and mefloquine [ATC Code]
- artesunate and pyronaridine [ATC Code]
- artesunate, sulfalene and pyrimethamine [ATC Code]
- biguanides [ATC Code]
- chloroquine [ATC Code]
- diaminopyrimidines [ATC Code]
- halofantrine [ATC Code]
- hydroxychloroquine [ATC Code]
- methanolquinolines [ATC Code]
- other antimalarials [ATC Code]
- primaquine [ATC Code]
- pyrimethamine [ATC Code]
- pyrimethamine, combinations [ATC Code]
- quinine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antimalarial [ICHI extension code]
- Antimalarial (disposition) [SNOMED CT concept]
- Autoimmune polyendocrinopathy [ORDO Disease]
- Pulmonary arterial trunk [FMA entity]
- Pulmonary artery [FMA entity]
- Pulmonary trunk [FMA entity]
- antimalarial agent [COVID-19 Thesaurus concept]
- other antimalarials [ATC Code]
CISMeF manual mappings
- Anti-infective antimalarial [ICD-11 Extension code]
- Substance with antimalarial mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Antimalarial [ICD-11 Extension code]
- Antimalarial Agent [NCIt concept]
- Product containing antimalarial (product) [SNOMED CT concept]
- antimalarial agent, nos [SNOMED Notion]
- antimalarials [ATC Code]
False automatic mappings
- Antiphospholipid syndrome [ORDO Disease]
Indexing information
- 1,2,6,7-tetraoxaspiro(7.11)nonadecane [MeSH Supplementary Concept]
- 17-O-acetyl,10-hydroxycorynantheol [MeSH Supplementary Concept]
- 19-hydroxypsammaplysin E [MeSH Supplementary Concept]
- 2',3'-dideoxycarbocyclic thymidine [MeSH Supplementary Concept]
- 3',4',7-trihydroxyflavone [MeSH Supplementary Concept]
- 3'-oxo-tabernaelegantine A [MeSH Supplementary Concept]
- 3-bromo-N-(4-fluorobenzyl)-benzo(b)thiophene-2-carboxamide [MeSH Supplementary Concept]
- 5-chloro-1-(1-(3-(7-chloroquinolin-4-ylamino)propyl)-1H-(1,2,3)triazol-4-ylmethyl)-1H-indole-2,3-dione [MeSH Supplementary Concept]
- 6-(1,2,6,7-tetraoxaspiro(7.11)nonadec-4-yl)hexan-1-ol [MeSH Supplementary Concept]
- 6-(1-(benzylamino)ethyl)-2,2-dimethyl-2H-chromen-7-ol [MeSH Supplementary Concept]
- 6-iodouridine [MeSH Supplementary Concept]
- 97-63 compound [MeSH Supplementary Concept]
- 97-78 compound [MeSH Supplementary Concept]
- N-(3-((1-tert-butyl-1H-tetrazol-5-yl)(pyrrolidin-1-yl)methyl)phenyl)-7-chloroquinolin-4-amine [MeSH Supplementary Concept]
- N-benzyl-1-(7-methoxy-2,2-dimethyl-2H-chromen-6-yl)ethanamine [MeSH Supplementary Concept]
- aerucyclamide C [MeSH Supplementary Concept]
- aerucyclamide D [MeSH Supplementary Concept]
- apicidin F [MeSH Supplementary Concept]
- arterolane [MeSH Supplementary Concept]
- aurachin E [MeSH Supplementary Concept]
- cecropin A [MeSH Supplementary Concept]
- ethyl 5-((2,5-dimethyl-1-(2-(trifluoromethyl)phenyl)pyrrol-3-yl)methylene)-2-methyl-4-oxo-1H-pyrrole-3-carboxylate [MeSH Supplementary Concept]
- farneside A [MeSH Supplementary Concept]
- hemozoin [MeSH Supplementary Concept]
- kabiramide I [MeSH Supplementary Concept]
- kabiramide L [MeSH Supplementary Concept]
- katimborine [MeSH Supplementary Concept]
- nepodin [MeSH Supplementary Concept]
- omubioside [MeSH Supplementary Concept]
- plasmodione [MeSH Supplementary Concept]
- saccharosporone A [MeSH Supplementary Concept]
- saccharosporone B [MeSH Supplementary Concept]
- saccharosporone C [MeSH Supplementary Concept]
- sinococuline [MeSH Supplementary Concept]
- steenkrotin A [MeSH Supplementary Concept]
- sulfadoxine-pyrimethamine-artesunate [MeSH Supplementary Concept]
- tazopsine [MeSH Supplementary Concept]
Record concept(s)
- antimalarials [MeSH concept]
See also
- antirheumatic agents [MeSH Descriptor]
- malaria [MeSH Descriptor]
- plasmodium [MeSH Descriptor]
See also (suggested by CISMeF)
- malaria [MeSH Descriptor]
- malaria, falciparum [MeSH Descriptor]
See also inter- (CISMeF)
- Medicinal product acting as antimalarial agent (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,3-dichloro-6-trifluoromethyl-9-phenanthryl-3-(n-butyl)aminopropanol [MeSH Supplementary Concept]
- 1-(5-(4-bromo-2-chlorophenyl)furan-2-yl)-N-((piperidin-4-yl)methyl)methanamine [MeSH Supplementary Concept]
- 3-amino-2-hydroxy-4-phenylbutanoic acid [MeSH Supplementary Concept]
- 3-methylchloroquine [MeSH Supplementary Concept]
- 4-aminoquinoline [MeSH Supplementary Concept]
- 5'-deoxy-5'-S-isobutylthioadenosine [MeSH Supplementary Concept]
- 5'-methylthioadenosine [MeSH Supplementary Concept]
- 6-methoxy-8-(3-diethylaminopropylamino)quinoline [MeSH Supplementary Concept]
- 7-isocyano-11(20),14-epiamphilectadiene [MeSH Supplementary Concept]
- Artemether [MeSH Descriptor]
- Artemether, Lumefantrine Drug Combination [MeSH Descriptor]
- Artesunate [MeSH Descriptor]
- BRL 6231 [MeSH Supplementary Concept]
- E 64 [MeSH Supplementary Concept]
- Lumefantrine [MeSH Descriptor]
- RV 538 [MeSH Supplementary Concept]
- SC83288 [MeSH Supplementary Concept]
- Trimethoprim, Sulfamethoxazole Drug Combination [MeSH Descriptor]
- acedapsone [MeSH Descriptor]
- amariin [MeSH Supplementary Concept]
- amodiaquine [MeSH Descriptor]
- amodiaquine, artesunate drug combination [MeSH Supplementary Concept]
- annimycin [MeSH Supplementary Concept]
- artefenomel [MeSH Supplementary Concept]
- arteflene [MeSH Supplementary Concept]
- artemisinins [MeSH Descriptor]
- artemotil [MeSH Supplementary Concept]
- artenimol [MeSH Supplementary Concept]
- atovaquone [MeSH Descriptor]
- atovaquone, proguanil drug combination [MeSH Supplementary Concept]
- cecropin B protein, insecta [MeSH Supplementary Concept]
- chloroquine [MeSH Descriptor]
- chloroquine diphosphate [MeSH Supplementary Concept]
- chlorproguanil [MeSH Supplementary Concept]
- cinchonine [MeSH Supplementary Concept]
- cryptolepine [MeSH Supplementary Concept]
- curdlan sulfate [MeSH Supplementary Concept]
- cycloguanil [MeSH Supplementary Concept]
- dapsone [MeSH Descriptor]
- dermaseptin [MeSH Supplementary Concept]
- doxycycline [MeSH Descriptor]
- fanasil, pyrimethamine drug combination [MeSH Supplementary Concept]
- ferroquine [MeSH Supplementary Concept]
- halofantrine [MeSH Supplementary Concept]
- hydroxychloroquine [MeSH Descriptor]
- lapachol [MeSH Supplementary Concept]
- magainin 1 peptide, xenopus [MeSH Supplementary Concept]
- maloprim [MeSH Supplementary Concept]
- mefloquine [MeSH Descriptor]
- mefloquine-sulfadoxine-pyrimethamine [MeSH Supplementary Concept]
- mirincamycin [MeSH Supplementary Concept]
- mizoribine [MeSH Supplementary Concept]
- monorden [MeSH Supplementary Concept]
- parvaquone [MeSH Supplementary Concept]
- pepstatin [MeSH Supplementary Concept]
- piperaquine [MeSH Supplementary Concept]
- primaquine [MeSH Descriptor]
- proguanil [MeSH Descriptor]
- pyrimethamine [MeSH Descriptor]
- pyronaridine [MeSH Supplementary Concept]
- quinacrine [MeSH Descriptor]
- quinidine [MeSH Descriptor]
- quinidine gluconate [MeSH Supplementary Concept]
- quinine [MeSH Descriptor]
- silicon phthalocyanine [MeSH Supplementary Concept]
- sinefungin [MeSH Supplementary Concept]
- spirogermanium [MeSH Supplementary Concept]
- sulfadoxine [MeSH Descriptor]
- sulfalene [MeSH Descriptor]
- tafenoquine [MeSH Supplementary Concept]
- tetrandrine [MeSH Supplementary Concept]
- trimethoprim [MeSH Descriptor]
UMLS correspondences (same concept)
- Anti-infective antimalarial [ICD-11 Extension code]
- Antimalarial [ICD-11 Extension code]
- Antimalarial Agent [NCIt concept]
- Medicinal product acting as antimalarial agent (product) [SNOMED CT concept]
- Product containing antimalarial (product) [SNOMED CT concept]
- Substance with antimalarial mechanism of action (substance) [SNOMED CT concept]
- antimalarial agent, nos [SNOMED Notion]
- antimalarials [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients